Oral Ad5 Vector‐Based SARS‐CoV‐2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice

Documenti analoghi

• A Novel Circular Delta‐XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS‐CoV‐2 Variants in Mice
  di: Kangyin Li, et al.
  Pubblicazione: (2024)
• Erratum to “Evaluation of the Effectiveness and Safety of Sequential Vaccination With Inactivated SARS‐CoV‐2 Vaccine and Ad5‐nCoV Booster in Pediatric Liver Transplant Recipients”
  Pubblicazione: (2024)
• Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections
  di: Jianhua Li, et al.
  Pubblicazione: (2025)
• Maternal Vaccination and Protective Immunity Against SARS‐CoV‐2 Infection in Pups
  di: Kunpeng Liu, et al.
  Pubblicazione: (2025)
• Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS‐CoV‐2 Vaccine and the Resultant Neutralization Activity
  di: Jing Wang, et al.
  Pubblicazione: (2024)